Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
46.41
+1.54 (3.43%)
Mar 25, 2026, 4:00 PM EDT
Market Cap5.03B +31.0%
Revenue (ttm)435.52M -0.5%
Net Income52.06M +3.8%
EPS0.48 +4.2%
Shares Out108.29M
PE Ratio95.96
Forward PEn/a
Dividend0.20 (0.45%)
Ex-Dividend DateMay 20, 2025
Volume3,842,410
Average Volume5,180,286
Open44.97
Previous Close44.87
Day's Range44.81 - 48.17
52-Week Range24.60 - 53.99
Beta-0.95
RSI56.19
Earnings DateApr 16, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 696
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2024, SHE:301281's revenue was 463.72 million, an increase of 3.60% compared to the previous year's 447.58 million. Earnings were 60.27 million, a decrease of -21.76%.

Financial Statements